Usefulness of Intraluminal Brachytherapy Combined With External Beam Radiation Therapy for Submucosal Esophageal Cancer: Long-Term Follow-Up Results

International Journal of Radiation Oncology Biology Physics

Volumn 76, Issue 2, 2010, Pages 452-459

  Ishikawa, Hitoshi ^a   Nonaka, Tetsuo ^a   Sakurai, Hideyuki ^a   Tamaki, Yoshio ^b   Kitamoto, Yoshizumi ^b   Ebara, Takeshi ^a   Shioya, Mariko ^a   Noda, Shin Ei ^a   Shirai, Katsuyuki ^b   Suzuki, Yoshiyuki ^a   Takahashi, Takeo ^a   Nakano, Takashi ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Gunma Prefectural Cancer Center   (Japan)

Author keywords

Brachytherapy; Esophageal cancer; Prognostic factor; Radiation therapy; Survival

Indexed keywords

BRACHYTHERAPY; CAUSE-SPECIFIC SURVIVAL; DISTANT METASTASIS; ESOPHAGEAL CANCER; EXTERNAL BEAM; EXTERNAL BEAM RADIATION THERAPY; HIGH DOSE RATE; INTRALUMINAL; LOCAL CONTROL; LONG-TERM FOLLOW-UP; LONG-TERM OUTCOME; LOW DOSE RATE; MEDICALLY INOPERABLE; MULTI VARIATE ANALYSIS; PROGNOSTIC FACTORS; RADIATION THERAPY; SALVAGE TREATMENT; SURVIVAL PROBABILITIES; TREATMENT MODALITY; UP TIME;

CESIUM; CHEMOTHERAPY; DECISION MAKING; IRIDIUM; MULTIVARIANT ANALYSIS; ONCOLOGY;

RADIOTHERAPY;

ANTINEOPLASTIC AGENT; CESIUM 137; IRIDIUM 192;

ADULT; AGED; ARGON LASER; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS ULCER; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HEART DISEASE; HUMAN; HUMAN TISSUE; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIMEDIA; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; RESPIRATORY TRACT DISEASE; RETREATMENT; SALVAGE THERAPY; SUBMUCOSA; SURVIVAL RATE;

AGED; AGED, 80 AND OVER; BRACHYTHERAPY; CESIUM RADIOISOTOPES; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; SURVIVAL RATE;

EID: 73649141320     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.02.029     Document Type: Article

References (36)

1. Mori M., Adachi Y., Matsushima T., et al. Lugol staining pattern and histology of esophageal lesions. Am J Gastroenterol 88 (1993) 701-705
2. Comprehensive Registry of Esophageal Cancer in Japan (1998, 1999) & Long Term Results of Esophagectomy in Japan (1988-1997). 3rd edition (2002), The Japanese Society for Esophageal Disease
3. Takubo K., Aida J., Sawabe M., et al. Early squamous cell carcinoma of the oesophagus: The Japanese viewpoint. Histopathology 51 (2007) 733-742
4. Inoue H., Honda T., Nagai K., et al. Ultrahigh magnification endoscopic observation of carcinoma in situ of the edophagus. Dig Endosc 9 (1997) 16-18
5. Matsuda T., Marugame T., Kamo K., et al. Cancer incidence and incidence rates in Japan in 2002: based on data from 11 population-based cancer registries. Jpn J Clin Oncol 38 (2008) 641-648
6. Tajima Y., Naknishi Y., Ochiai, et al. Histopathologic findings predicting lymph node metastasis and prognosis of patients with superficial esophageal carcinoma: Analysis of 240 surgically resected tumors. Cancer 88 (2000) 1285-1293
7. Holscher A.H., Bollschweiler E., Schneider P.M., et al. Prognosis of early esophageal cancer. Cancer 76 (1995) 178-186
8. Igaki H., Kato H., Tachimori Y., et al. Clinicopathological characteristics and survival of patients with clinical Stage I squamous cell carcinomas of the thoracic esophagus treated with three-field lymph node dissection. Eur J Cardiothorac Surg 20 (2001) 1089-1094
9. Sugimachi K., Watanabe M., Sadanaga N., et al. Recent advances in the diagnosis and surgical treatment of patients with carcinoma of the esophagus. J Am Coll Surg 178 (1994) 363-368
10. Shimada H., Nabeya Y., Matsubara H., et al. Prediction of lymph node status in patients with superficial esophageal carcinoma: analysis of 160 surgically resected cancers. Am J Surg 191 (2006) 250-254
11. Kim D.U., Lee J.H., Min B.H., et al. Risk factors of lymph node metastasis in T1 esophageal squamous cell carcinoma. J Gastroenterol Hepatol 23 (2008) 619-625
12. Moskovitz A.H., Rizk N.P., Venkatraman E., et al. Mortality increases for octogenarians undergoing esophagogastrectomy for esophageal cancer. Ann Thorac Surg 82 (2006) 2031-2036
13. Kinugasa S., Tachibana M., Yoshimura H., et al. Esophageal resection in elderly esophageal carcinoma patients: improvement in postoperative complications. Ann Thorac Surg 71 (2001) 414-418
14. Ferguson M.K., Martin T.R., Reeder L.B., et al. Mortality after esophagectomy: risk factor analysis. World J Surg 21 (1997) 599-603
15. Okawa T., Dokiya T., Nishio M., et al. Multi-institutional randomized trial of external radiotherapy with and without intraluminal brachytherapy for esophageal cancer in Japan. Japanese Society of Therapeutic Radiology and Oncology (JASTRO) Study Group. Int J Radiat Oncol Biol Phys 45 (1999) 623-628
16. Nemoto K., Yamada S., Nishio M., et al. Results of radiation therapy for superficial esophageal cancer using the standard radiotherapy method recommended by the Japanese Society of Therapeutic Radiology and Oncology (JASTRO) Study Group. Anticancer Res 26 (2006) 1507-1512
17. Nishimura Y., Okuno Y., Ono K., Mitsumori M., Nagata Y., and Hiraoka M. External beam radiation therapy with or without high-dose-rate intraluminal brachytherapy for patients with superficial esophageal carcinoma. Cancer 86 (1999) 220-228
18. Sai H., Mitsumori M., Araki N., et al. Long-term results of definitive radiotherapy for stage I esophageal cancer. Int J Radiat Oncol Biol Phys 62 (2005) 1339-1344
19. Sasaki T., Nakamura K., Shioyama Y., et al. Treatment outcomes of radiotherapy for patients with stage I esophageal cancer: a single institute experience. Am J Clin Oncol 30 5 (2007 Oct) 514-519
20. Nemoto K., Matsumoto Y., Yamakawa M., et al. Treatment of superficial esophageal cancer by external radiation therapy alone: results of a multi-institutional experience. Int J Radiat Oncol Biol Phys 46 (2000) 921-925
21. Ishikawa H., Sakurai H., Tamaki Y., et al. Radiation therapy alone for stage I (UICC T1N0M0) squamous cell carcinoma of the esophagus: Indications for surgery or combined chemoradiotherapy. J Gastroenterol Hepatol 21 (2006) 1290-1296
22. Ishikawa H., Sakurai H., Yamakawa M., et al. Clinical outcomes and prognostic factors for patients with early esophageal squamous cell carcinoma treated with definitive radiation therapy alone. J Clin Gastroenterol 39 (2005) 495-500
23. Cox J.D., Stetz J., and Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31 (1995) 1341-1346
24. Kaplan E., and Meier P. Non-parametric estimation from incomplete observation. J Am Stat Assoc 53 (1958) 457-481
25. Kodama M., and Kakegawa T. Treatment of superficial cancer of the esophagus: A summary of response to a questionnaire on superficial cancer of the esophagus in Japan. Surgery 123 (1998) 432-439
26. Fujita H., Sueyoshi S., Yamana H., et al. Optimum treatment strategy for superficial esophageal cancer: Endoscopic mucosal resection vs. radical esophagectomy. World J Surg 25 (2001) 424-431
27. Eguchi T., Nakanishi Y., Shimada T., et al. Histopathological criteria for additional treatment after endoscopic mucosal resection for esophageal cancer: analysis of 464 surgically resected cases. Modern Pathol 19 (2006) 475-480
28. Cooper J.S., Guo M.D., Herskovic A., et al. Chemoradiotherapy of locally advanced esophageal cancer: Long-term follow-up of a prospective randomized trial (RTOG 85-01)-Radiation Therapy Oncology Group. JAMA 281 (1999) 1623-1627
29. Smith T.J., Ryan L.M., Douglass Jr. H.O., et al. Combined chmoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: A study of the Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys 42 (1998) 269-276
30. Stockeld D., Tennvall J., Wagenius G., et al. A Swedish study of chemoradiation in squamous cell carcinoma of the esophagus. Acta Oncol 40 (2001) 566-573
31. Hironaka S., Ohtsu A., Boku N., et al. Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2-3)/N(any)/M(0) squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 57 (2003) 425-433
32. Ishikura S., Nihei K., Ohtsu A., et al. Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol 21 (2003) 2697-2702
33. Minsky B.D., Pajak T.F., Ginsberg R.J., et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 20 (2002) 1167-1174
34. Wei X., Liu H.H., Tucker S.L., et al. Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy. Int J Radiat Oncol Biol Phys 70 (2008) 707-714
35. Liao Z., Cox J.D., and Komaki R. Radiochemotherapy of esophageal cancer. J Thorac Oncol 2 (2007) 553-568
36. Yamada S., Nemoto K., Takai Y., et al. Standard radiotherapy methods for superficial esophageal cancer. J Jpn Soc Ther Radiol Oncol 12 (2000) 169-176